Sanofi stock before the bell gains on Cheplapharm deal
Published on 09/17/2026 at 07:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi stock closed at USD 42.67 on September 16, 2026, up 0.45 percent on the session. Sanofi (ISIN FR0000127771) also finished with a 52-week range of USD 42.59 to USD 77.25, placing the close near the lower end of that band.
September 16, 2026 in numbers
As MarketScreener reported, Reuters cited Cheplapharm saying the German drugmaker sees room for a deeper relationship after Sanofi agreed to transfer 20 mature medicines and three manufacturing sites in exchange for a 26.4 percent stake in the company. That deal was the main verifiable session driver in the available reports.
Sanofi stock traded at USD 42.67 versus a prior close of USD 42.48, and the session move was 0.45 percent. The close sat inside the quoted 52-week range of USD 42.59 to USD 77.25, while the wider US market ended lower, with the S and P 500 down 0.4 percent on September 16, 2026.
Today ahead of the open
According to Bolsamania, Sanofi's strategic agreement with Cheplapharm is among the corporate items circulating today. The Federal Reserve decision due today also remains a market focus for large European drug shares, which often trade against the broader risk backdrop.
